Kavaliauskas Povilas, Grybaitė Birutė, Vaickelionienė Rita, Sapijanskaitė-Banevič Birutė, Anusevičius Kazimieras, Kriaučiūnaitė Agnė, Smailienė Gabrielė, Petraitis Vidmantas, Petraitienė Rūta, Naing Ethan, Garcia Andrew, Mickevičius Vytautas
Department of Organic Chemistry, Kaunas University of Technology, Radvilėnų Rd. 19, LT-50254 Kaunas, Lithuania.
Transplantation-Oncology Infectious Diseases Program, Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine of Cornell University, 1300 York Ave., New York, NY 10065, USA.
Antibiotics (Basel). 2023 Jan 20;12(2):220. doi: 10.3390/antibiotics12020220.
The growing antimicrobial resistance to last-line antimicrobials among Gram-positive pathogens remains a major healthcare emergency worldwide. Therefore, the search for new small molecules targeting multidrug-resistant pathogens remains of great importance. In this paper, we report the synthesis and in vitro antimicrobial activity characterisation of novel thiazole derivatives using representative Gram-negative and Gram-positive strains, including tedizolid/linezolid-resistant as well as emerging fungal pathogens. The 4-substituted thiazoles , and with naphthoquinone-fused thiazole derivative with excellent activity against methicillin and tedizolid/linezolid-resistant . Moreover, compounds , and showed favourable activity against vancomycin-resistant . Compounds and showed broad-spectrum antifungal activity against drug-resistant strains, while ester showed good activity against which was greater than fluconazole. Collectively, these data demonstrate that -2,5-dimethylphenylthioureido acid derivatives could be further explored as novel scaffolds for the development of antimicrobial candidates targeting Gram-positive bacteria and drug-resistant pathogenic fungi.
革兰氏阳性病原体对最后一线抗菌药物的耐药性不断增加,这在全球范围内仍然是一个重大的医疗紧急情况。因此,寻找针对多重耐药病原体的新型小分子仍然非常重要。在本文中,我们报告了使用代表性的革兰氏阴性和革兰氏阳性菌株,包括对泰地唑胺/利奈唑胺耐药的菌株以及新出现的真菌病原体,合成新型噻唑衍生物并对其进行体外抗菌活性表征。4-取代噻唑以及具有萘醌稠合的噻唑衍生物对耐甲氧西林和耐泰地唑胺/利奈唑胺的菌株具有优异的活性。此外,化合物、和对耐万古霉素的菌株表现出良好的活性。化合物和对耐药菌株表现出广谱抗真菌活性,而酯对的活性优于氟康唑。总体而言,这些数据表明,-2,5-二甲基苯基硫脲酸衍生物可作为新型骨架进一步探索,用于开发针对革兰氏阳性细菌和耐药致病真菌的抗菌候选物。